Abstract:Background: Papillary thyroid carcinoma (PTC) is the most common thyroid malignancy, but little is known regarding PTC metabolic phenotypes and the effects of mitochondrial activity on PTC progression. The great potential of mitochondria-targeting therapy in cancer treatment promoted us to use tool compounds from a family of Mito-Fu derivatives to investigate how the regulation of mitochondrial respiration affected tumor progression characteristics and molecular changes in PTC. Methods: Mito-Fu L20, a representative of 12 synthetic derivatives, was chosen for mitochondrial inhibition experiments. Sample sections from PTC patients were collected and processed to explore potential molecular alterations in tumor lymph node metastasis (LNM). In vitro analyses were performed using human PTC cell lines (K1 and TPC-1), with the human normal thyroid follicular cell line (Nthy) as a control. K1 cells were injected into nude mice to generate an animal model. The mice were injected with normal saline or Mito-Fu L20 at 20 or 50 mg/kg every other day; their body weights and tumor volumes were also measured over time. To elucidate the resulting metabolic phenotype, we measured oxygen consumption rate (OCR) and extracellular acidification rate (ECAR), cellular adenosine triphosphate (ATP) levels and reactive oxygen species (ROS) production, and mitochondrial membrane potential. Wound healing and Transwell assays, cell cycle assays, real-time fluorescence quantitative PCR, Western blotting, and immunohistochemical staining were performed to explore glycolysis-dominant metabolism in PTC. Results: Cyclin D1 and mitochondrial complex IV were detected in tumor samples from PTC patients with LNM. Mito-Fu L20 showed dose-independent and reversible modulation of mitochondrial respiration in PTC. In addition to mitochondrial dysfunction and early apoptosis, G1/S phase arrest. Notably, reversible mitochondrial inhibition yielded durable suppression of tumor proliferation, migration, and invasion via the PI3K/Akt/FoxO1/Cyclin D1 pathway. In vivo experiments demonstrated that Mito-Fu L20 has a good safety profile and specific restorative effect on mitochondrial activity in the liver. In addition, Mito-Fu L20 showed antitumor effects, alleviated tumor angiogenesis, and improved thyroid function. Conclusion: Reversible inhibition of ATP production and durable suppression of PTC growth indicates that the downregulation of mitochondrial function has a negative impact on tumor progression and LNM via the PI3K/Akt/FoxO1/Cyclin D1 pathway. The results provide new insights into the antitumor potential and clinical translation of mitochondrial inhibitors.

Effects of Insulin Analogs and Glucagon-Like Peptide-1 Receptor Agonists on Proliferation and Cellular Energy Metabolism in Papillary Thyroid Cancer

Insulin Analogs Detemir, Glargine And Lispro Enhance Proliferation Of Human Thyroid And Gastric Normal Or Cancer Cell Lines

Ang1/Tie2 Induces Cell Proliferation and Migration in Human Papillary Thyroid Carcinoma Via the PI3K/AKT Pathway

Exploring the clinical utility of DPP-IV and SGLT2 inhibitors in papillary thyroid cancer: a literature review

Targeting Glycogen Metabolism as a Novel Therapeutic Approach in Anaplastic Thyroid Cancer

Effects of Insulin, Insulin-Like Growth Factor-I and -II on Proliferation and Intracellular Signaling in Endometrial Carcinoma Cells with Different Expression Levels of Insulin Receptor Isoform A.

Mitochondrial Respiration Inhibition Suppresses Papillary Thyroid Carcinoma Via PI3K/Akt/FoxO1/Cyclin D1 Pathway

Pyruvate Carboxylase Promotes Malignant Transformation of Papillary Thyroid Carcinoma and Reduces Iodine Uptake.

LDHA Induces EMT Gene Transcription and Regulates Autophagy to Promote the Metastasis and Tumorigenesis of Papillary Thyroid Carcinoma

NEAT1_2/RRAD/EHF Positive Feedback Loop Facilitates Aerobic Glycolysis in Papillary Thyroid Cancer Cells

Circ_100395 Impedes Malignancy and Glycolysis in Papillary Thyroid Cancer: Involvement of PI3K/AKT/mTOR Signaling Pathway.

Fasting Regulates Mitochondrial Function Through Lncrna PRKCQ-AS1-mediated IGF2BPs in Papillary Thyroid Carcinoma

STAT1-induced Upregulation of Lncrna LINP1 Promotes Cell Proliferation and Inhibits Apoptosis Via AMPK Signaling Pathway in Papillary Thyroid Cancer

Activation of Glucagon-Like Peptide-1 Receptor Inhibits Tumourigenicity and Metastasis of Human Pancreatic Cancer Cells Via PI3K/Akt Pathway.

ANGPTL4 Promotes the Proliferation of Papillary Thyroid Cancer via AKT Pathway.

Iodide- and Glucose-Handling Gene Expression Regulated by Sorafenib or Cabozantinib in Papillary Thyroid Cancer.

Pyruvate carboxylase promotes thyroid cancer aggressiveness through fatty acid synthesis

Genetic Alterations in the Phosphoinositide 3-Kinase/akt Signaling Pathway Confer Sensitivity of Thyroid Cancer Cells to Therapeutic Targeting of Akt and Mammalian Target of Rapamycin.

Apatinib Inhibits Cell Proliferation and Induces Autophagy in Human Papillary Thyroid Carcinoma Via the PI3K/Akt/mTOR Signaling Pathway

Growth-Inhibitory Effects Of Human Anti-Insulin-Like Growth Factor-I Receptor Antibody (A12) In An Orthotopic Nude Mouse Model Of Ana Plastic Thyroid Carcinoma

Metformin Reduces Glycometabolism of Papillary Thyroid Carcinoma in Vitro and in Vivo.